Published in Cancer Res on July 01, 1983
Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2'-deoxycoformycin. Proc Natl Acad Sci U S A (1984) 1.46
Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency. Blood (2011) 0.90
S-Adenosylhomocysteine hydrolase from human placenta. Affinity purification and characterization. Biochem J (1985) 0.85
Clinical expression, genetics and therapy of adenosine deaminase (ADA) deficiency. J Inherit Metab Dis (1997) 0.78
Evolution of the arabinosides and the pharmacology of fludarabine. Drugs (1994) 0.77
Covalent labelling of ligand binding sites of human placental S-adenosylhomocysteine hydrolase with 8-azido derivatives of adenosine and cyclic AMP. Biochem J (1985) 0.75
Pain in sickle cell disease. Rates and risk factors. N Engl J Med (1991) 9.75
Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med (1998) 7.07
Unintended changes in cognition, mood, and behavior arising from cell-based interventions for neurological conditions: ethical challenges. Am J Bioeth (2009) 6.13
Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med (2001) 5.14
The enzymic synthesis of L-cysteine in Escherichia coli and Salmonella typhimurium. J Biol Chem (1966) 4.26
Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med (2000) 4.14
The use of proteolytic enzymes to improve immunoglobulin staining by the PAP technique. Histochem J (1979) 4.06
T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates. Nat Med (1998) 3.95
Regulation of L-cysteine biosynthesis in Salmonella typhimurium. I. Effects of growth of varying sulfur sources and O-acetyl-L-serine on gene expression. J Biol Chem (1971) 3.19
Mortality in children and adolescents with sickle cell disease. Cooperative Study of Sickle Cell Disease. Pediatrics (1989) 2.74
Effect of spectinomycin use on the prevalence of spectinomycin-resistant and of penicillinase-producing Neisseria gonorrhoeae. N Engl J Med (1987) 2.70
Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. Proc Natl Acad Sci U S A (1989) 2.45
Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood (1990) 2.38
A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood (1993) 2.29
Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J Clin Invest (1991) 2.28
Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript. Proc Natl Acad Sci U S A (1989) 2.23
Characterization of glass adherent human mononuclear cells. J Immunol (1973) 2.22
Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation. J Immunol (1986) 2.11
Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant (2001) 2.10
Role of S-adenosylhomocysteine in adenosinemediated toxicity in cultured mouse T lymphoma cells. Cell (1977) 2.09
Ethical aspects of banking placental blood for transplantation. JAMA (1995) 2.07
The spectrum of brain MR abnormalities in sickle-cell disease: a report from the Cooperative Study of Sickle Cell Disease. AJNR Am J Neuroradiol (1996) 2.05
The purification and characterization of O-acetylserine sulfhydrylase-A from Salmonella typhimurium. J Biol Chem (1969) 2.04
Successful therapy for trilateral retinoblastoma. Am J Ophthalmol (1992) 2.03
DNA sequences of the cysK regions of Salmonella typhimurium and Escherichia coli and linkage of the cysK regions to ptsH. J Bacteriol (1988) 2.01
Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia. J Clin Oncol (2001) 1.96
Purification and characterization of cysteine synthetase, a bifunctional protein complex, from Salmonella typhimurium. J Biol Chem (1969) 1.96
DNA sequences of the cysB regions of Salmonella typhimurium and Escherichia coli. J Biol Chem (1987) 1.95
Purinogenic immunodeficiency diseases: selective toxicity of deoxyribonucleosides for T cells. Proc Natl Acad Sci U S A (1978) 1.93
Requirement of S-adenosyl-L-methionine-mediated methylation for human monocyte chemotaxis. Proc Natl Acad Sci U S A (1978) 1.89
Serotype-specific immunoglobulin G antibody responses to pneumococcal polysaccharide vaccine in children with sickle cell anemia: effects of continued penicillin prophylaxis. J Pediatr (1996) 1.84
Cord Blood Transplantation Study (COBLT): cord blood bank standard operating procedures. J Hematother (1998) 1.82
Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase. N Engl J Med (1987) 1.75
Apparent suicide inactivation of human lymphoblast S-adenosylhomocysteine hydrolase by 2'-deoxyadenosine and adenine arabinoside. A basis for direct toxic effects of analogs of adenosine. J Biol Chem (1979) 1.73
Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr (2001) 1.71
Bacteremia in sickle hemoglobinopathies. J Pediatr (1986) 1.69
Sickle cell disease in children and adolescents: the relation of child and parent pain coping strategies to adjustment. J Pediatr Psychol (1991) 1.67
Phenotypic variation in the response to the human immunodeficiency virus among derivatives of the CEM T and WIL-2 B cell lines. J Exp Med (1988) 1.67
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl J Med (1988) 1.67
Consensus nomenclature for the mammalian methionine adenosyltransferase genes and gene products. Trends Genet (1997) 1.67
Early events in human T cell ontogeny. Phenotypic characterization and immunohistologic localization of T cell precursors in early human fetal tissues. J Exp Med (1988) 1.62
High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J Clin Oncol (1993) 1.61
Cell-based interventions for neurologic conditions: ethical challenges for early human trials. Neurology (2008) 1.57
Establishment of the DU.528 human lymphohemopoietic stem cell line. J Exp Med (1985) 1.56
Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia. Leukemia (2011) 1.55
Guanine ribonucleotide depletion inhibits T cell activation. Mechanism of action of the immunosuppressive drug mizoribine. J Clin Invest (1991) 1.55
Mithramycin blocks protein binding and function of the SV40 early promoter. J Clin Invest (1989) 1.53
Laboratory correlates and prognostic significance of granular acute lymphoblastic leukemia in children. A Pediatric Oncology Group study. Am J Clin Pathol (1991) 1.52
Environmental factors in the etiology of rhabdomyosarcoma in childhood. J Natl Cancer Inst (1982) 1.52
Central nervous system bleeding in hemophiliacs. Blood (1978) 1.51
Umbilical cord blood hematopoietic stem and repopulating cells in human clinical transplantation. Blood Cells (1991) 1.50
Cooperative Study of Sickle Cell Disease: Demographic and socioeconomic characteristics of patients and families with sickle cell disease. J Chronic Dis (1985) 1.49
Prevalence and clinical correlates of glomerulopathy in children with sickle cell disease. J Pediatr (2000) 1.48
Molecular characterization of the cysJIH promoters of Salmonella typhimurium and Escherichia coli: regulation by cysB protein and N-acetyl-L-serine. J Bacteriol (1989) 1.47
Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy. N Engl J Med (1998) 1.47
In vivo inactivation of erythrocyte S-adenosylhomocysteine hydrolase by 2'-deoxyadenosine in adenosine deaminase-deficient patients. J Clin Invest (1979) 1.47
Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2'-deoxycoformycin. Proc Natl Acad Sci U S A (1984) 1.46
Combination treatment of bullous pemphigoid with anti-CD20 and anti-CD25 antibodies in a patient with chronic graft-versus-host disease. Bone Marrow Transplant (2002) 1.44
Evidence for susceptibility of intrathymic T-cell precursors and their progeny carrying T-cell antigen receptor phenotypes TCR alpha beta + and TCR gamma delta + to human immunodeficiency virus infection: a mechanism for CD4+ (T4) lymphocyte depletion. Proc Natl Acad Sci U S A (1990) 1.43
Human herpesvirus 6 limbic encephalitis after stem cell transplantation. Ann Neurol (2001) 1.43
Structure determination of selenomethionyl S-adenosylhomocysteine hydrolase using data at a single wavelength. Nat Struct Biol (1998) 1.42
Regulation of the human inosine monophosphate dehydrogenase type I gene. Utilization of alternative promoters. J Biol Chem (1997) 1.42
Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine. J Clin Oncol (2002) 1.42
Umbilical cord blood stem cells: application for the treatment of patients with hemoglobinopathies. J Pediatr (1997) 1.42
Ontogeny of T-cell precursors: a model for the initial stages of human T-cell development. Immunol Today (1989) 1.41
Brief report: hepatic dysfunction as a complication of adenosine deaminase deficiency. N Engl J Med (1996) 1.40
The use of enzyme therapy to regulate the metabolic and phenotypic consequences of adenosine deaminase deficiency in mice. Differential impact on pulmonary and immunologic abnormalities. J Biol Chem (2000) 1.40
Adenine and adenosine are toxic to human lymphoblast mutants defective in purine salvage enzymes. Science (1977) 1.40
Surgery and anesthesia in sickle cell disease. Cooperative Study of Sickle Cell Diseases. Blood (1995) 1.40
Effects of mutational loss of adenosine kinase and deoxycytidine kinase on deoxyATP accumulation and deoxyadenosine toxicity in cultured CEM human T-lymphoblastoid cells. J Biol Chem (1982) 1.39
Transient erythroblastopenia in the first year of life. Am J Hematol (1991) 1.39
High-dose oral dexamethasone therapy for chronic childhood idiopathic thrombocytopenic purpura. J Pediatr (1996) 1.39
Cancer in children of parents exposed to hydrocarbon-related industries and occupations. Am J Epidemiol (1980) 1.38
On the role of deoxyribonucleic acid polymerase in determining mutation rates. Characterization of the defect in the T4 deoxyribonucleic acid polymerase caused by the ts L88 mutation. J Biol Chem (1973) 1.38
The stoichiometry and kinetics of the inducible cysteine desulfhydrase from Salmonella typhimurium. J Biol Chem (1973) 1.38
Association of terminal deoxynucleotidyl transferase with Ku. Proc Natl Acad Sci U S A (1999) 1.36
Antibody responses to bacteriophage phi X174 in patients with adenosine deaminase deficiency. Blood (1992) 1.34
Nuclease activity in a fragment of bacteriophage T4 deoxyribonucleic acid polymerase induced by the amber mutant am B22. J Biol Chem (1971) 1.34
Regulation of de novo purine biosynthesis in human lymphoblasts. Coordinate control of proximal (rate-determining) steps and the inosinic acid branch point. J Biol Chem (1976) 1.34
T-Cell recovery in adults and children following umbilical cord blood transplantation. Biol Blood Marrow Transplant (2001) 1.33
Immunopathologic studies of an experimental model resembling Goodpasture's syndrome. Am J Pathol (1969) 1.33
Regulation of O-acetylserine sulfhydrylase B by L-cysteine in Salmonella typhimurium. J Bacteriol (1979) 1.33
Dissimilatory sulphite reductase from Archaeoglobus fulgidus: physico-chemical properties of the enzyme and cloning, sequencing and analysis of the reductase genes. J Gen Microbiol (1993) 1.33
Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignancies. J Clin Oncol (2005) 1.32
Structural analysis of the deoxycytidine kinase gene in patients with acute myeloid leukemia and resistance to cytosine arabinoside. Leukemia (1994) 1.32
The structural gene for O-acetylserine sulfhydrylase A in Salmonella typhimurium. Identity with the trzA locus. J Biol Chem (1974) 1.32
Mithramycin selectively inhibits transcription of G-C containing DNA. Am J Med Sci (1987) 1.31
S-adenosylhomocysteine hydrolase is an adenosine-binding protein: a target for adenosine toxicity. Science (1978) 1.31